These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 23159356)
1. The correlation between insulin-like growth factor II mRNA binding protein 3 expression in hepatocellular carcinoma and prognosis. Chen LT; Lin LJ; Zheng LL Hepatogastroenterology; 2013 May; 60(123):553-6. PubMed ID: 23159356 [TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
3. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection. Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916 [TBL] [Abstract][Full Text] [Related]
5. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma. Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813 [TBL] [Abstract][Full Text] [Related]
6. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. Yin F; Han X; Yao SK; Wang XL; Yang HC World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Ki67 Expression for Patients with Surgically Resected Hepatocellular Carcinoma: Perspectives from a High Incidence Area. Bai K; Cao Y; Huang Q; Jiang Y; Lv L Clin Lab; 2017 Feb; 63(2):355-364. PubMed ID: 28182353 [TBL] [Abstract][Full Text] [Related]
8. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer. Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma. Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768 [TBL] [Abstract][Full Text] [Related]
10. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962 [TBL] [Abstract][Full Text] [Related]
11. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955 [TBL] [Abstract][Full Text] [Related]
12. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma. Ahn S; Hyeon J; Park CK Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774 [TBL] [Abstract][Full Text] [Related]
13. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection. Chen RX; Xia YH; Cui JF; Xue TC; Ye SL J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235 [TBL] [Abstract][Full Text] [Related]
14. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma. Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276 [TBL] [Abstract][Full Text] [Related]
15. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
16. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays. Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386 [TBL] [Abstract][Full Text] [Related]
17. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study. Wang L; Li HG; Xia ZS; Lü J; Peng TS Chin Med J (Engl); 2010 Dec; 123(24):3554-8. PubMed ID: 22166630 [TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma. Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the clinical features of HCC following hepatectomy for different stages of HCC. Ma C; Chi M; Su H; Cheng X; Chen L; Kan Y; Wei W; Huang X; Li Y; Li L; Lin K; Huang Y; Wu Y; Huang X; Huang A; Liu J Hepatogastroenterology; 2012 Oct; 59(119):2104-11. PubMed ID: 23435129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]